Sign inJoin waitlistJoin the waitlist

Qamar Khan

Professor, Medical Oncology · University of Kansas School of Medicine

Credentials: · · · ·

History

University of Kansas School of Medicine
Present

Hematology and Medical Oncology
University of Kansas School of Medicine
1990–1993
Internal Medicine
Bridgeport Hospital
1987–1990
Medical
1986–1987
KING EDWARD MED COLL, LAHORE, WEST PAKISTAN
1982–1986

Research

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer
New England Journal of Medicine · 2016 · 452 citations
Adaptive Randomization of Neratinib in Early Breast Cancer
New England Journal of Medicine · 2016 · 292 citations
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer:…
JAMA Oncology · 2020 · 187 citations

Priyanka Sharma
23 papers
Anne O'Dea
17 papers · 4 as a fellow
Carol Fabian
13 papers
Lauren Nye
10 papers
Angela DeMichele
8 papers
Anne Wallace
8 papers
Anthony Elias
8 papers
Douglas Yee
8 papers
Jamie Wagner
8 papers
Judy Boughey
8 papers · 3 as a resident
Kathy Albain
8 papers
Laura Esserman
8 papers

Grants

The University of Kansas Cancer Center
National Cancer Institute · P30
Project lead · $620.9K · University of Kansas Medical Center
2012–2027

Clinical trials

To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment
Principal investigator · Unknown
University of Kansas Medical Center
2021–2025
Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer
Principal investigator · Unknown · Phase 2
Qamar Khan
2017–2023
Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
Principal investigator · Active not recruiting · Phase 2
Qamar Khan
2016–2026
Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer
Principal investigator · Unknown · Phase 2
University of Kansas Medical Center
2011–2017